Selena Bartlett, PhD
Director of Preclinical
Development, Gallo Center
Phone: (510) 985-3133
Email: selenab@gallo.ucsf.edu
Research
Most current therapies for alcohol and drug abuse
are based on counseling and behavioral modification.
These approaches help and are successful for some. To
date, the FDA has approved only a handful of
medications for alcohol abuse, and the effectiveness of
these medications is limited. Dr. Bartlett has
established and directs the Preclinical Development
Group, which is focused on the translation of basic
research discoveries into drugable targets and new
treatments for neurological diseases such as addiction,
pain, stress, anxiety, and depression. Dr. Bartlett's
research has led to findings that suggest possible
links between the neurochemical pathways for alcohol
and nicotine dependence, and between addiction and
compulsive eating.
Lab Members (Preclinical Development Group)
Jade
Bito-Onon, Staff Research Associate, jbitoonon@gallo.ucsf.edu
Susmita
Chatterjee, PhD, Postdoctoral Fellow, schatterjee@gallo.ucsf.edu
Allison Feduccia, PhD, Postdoctoral Research Fellow, afeduccia@gallo.ucsf.edu
Carolina
Haass-Koffler, Postdoctoral Fellow, chaasskoffler@gallo.ucsf.edu
Andrea Henry, Staff Research Associate, ahenry@gallo.ucsf.edu
Joan Holgate,
Specialist, jholgate@gallo.ucsf.edu
Rui Li, Research Student, rli@gallo.ucsf.edu
Douglas Mill, Research Student, dmill@gallo.ucsf.edu
Mohammed
Naeemuddin, Senior Staff Research Associate, mnaeemuddin@gallo.ucsf.edu
Carsten Nielsen, PhD,
Associate Research Scientist, cnielsen@gallo.ucsf.edu
Nathan Santos, Laboratory Assistant, nsantos@gallo.ucsf.edu
Jeffrey Simms, Manager
of Preclinical Development, jsimms@gallo.ucsf.edu
Subhashini Srinivasan, Postdoctoral Research Fellow, ssrinivasan@gallo.ucsf.edu
Publications
Selena Bartlett's publications
|
